Remdesivir Metabolite GS-441524 Effectively Inhibits SARS-CoV-2 Infection in Mouse Models
This article has been Reviewed by the following groups
Listed in
- Evaluated articles (ScreenIT)
Abstract
No abstract available
Article activity feed
-
-
SciScore for 10.1101/2020.10.26.353300: (What is this?)
Please note, not all rigor criteria are appropriate for all manuscripts.
Table 1: Rigor
Institutional Review Board Statement IACUC: All protocols were approved by the Animal Welfare Committee and all procedures used in this study complied with the guidelines and policies of the Animal Care and Use Committee. Randomization Immediately, they were randomly divided into two groups (each group had 9 mice). Blinding not detected. Power Analysis not detected. Sex as a biological variable PK analysis: SD rats (male, four animals per group) weighing 180–220 g were injected with GS-441514 intravenously (iv) and intragastricly (ig) at a dose of 30mg/kg. Cell Line Authentication not detected. Table 2: Resources
Antibodies Sentences Resources Cells were then incubated with a rabbit anti-SARS-CoV-2 nucleocapsid … SciScore for 10.1101/2020.10.26.353300: (What is this?)
Please note, not all rigor criteria are appropriate for all manuscripts.
Table 1: Rigor
Institutional Review Board Statement IACUC: All protocols were approved by the Animal Welfare Committee and all procedures used in this study complied with the guidelines and policies of the Animal Care and Use Committee. Randomization Immediately, they were randomly divided into two groups (each group had 9 mice). Blinding not detected. Power Analysis not detected. Sex as a biological variable PK analysis: SD rats (male, four animals per group) weighing 180–220 g were injected with GS-441514 intravenously (iv) and intragastricly (ig) at a dose of 30mg/kg. Cell Line Authentication not detected. Table 2: Resources
Antibodies Sentences Resources Cells were then incubated with a rabbit anti-SARS-CoV-2 nucleocapsid protein polyclonal antibody (Cat. No.: 40143-T62, Sino Biological), followed by an HRP-labeled goat anti-rabbit secondary antibody (Cat. No.: 109-035-088, Jackson ImmunoResearch Laboratories). anti-SARS-CoV-2 nucleocapsid proteinsuggested: (Proteintech Cat# 80026-1-RR, RRID:AB_2882944)anti-rabbitsuggested: NoneExperimental Models: Cell Lines Sentences Resources Calu-3 cells were cultured in DMEM supplemented with 20% FBS, 100 U/mL penicillin and streptomycin, and 1% NEAA at 37 °C in a humidified atmosphere of 5% CO2. Calu-3suggested: NoneAntiviral activity assays: Vero E6, calu-3 and coco-2 cells were seeded at 1 × 105 cells per well in 24-well plates. coco-2suggested: NoneLung homogenates were serially diluted and used to inoculate Vero E6 cells at 37°C for 1 h. Vero E6suggested: NoneExperimental Models: Organisms/Strains Sentences Resources Vero-E6 and caco-2 were cultured in DMEM supplemented with 10% FBS, 100 U/mL penicillin and streptomycin at 37 °C in a humidified atmosphere of 5% CO2. Vero-E6suggested: NoneThe modified intratracheal aerosolization was used to intratracheally delivery AAV vector (5×1011 GC) to lung tissue of 4-week-old BALB/c mice.35, 36 Briefly, mice were anesthetized with 2.5% isoflurane in O2 (1 L/min). BALB/csuggested: RRID:IMSR_ORNL:BALB/cRl)Software and Algorithms Sentences Resources The dose-response curves were plotted from viral RNA copies versus the drug concentrations using GraphPad Prism 6 software. qRT-PCR analysis: For SARS-CoV-2 supernatant RNA quantification, RNA was isolated by E.Z.N.A. GraphPad Prismsuggested: (GraphPad Prism, RRID:SCR_002798)Data analysis was performed with GraphPad Prism Software (GraphPad Software Inc. GraphPadsuggested: (GraphPad Prism, RRID:SCR_002798)Results from OddPub: We did not detect open data. We also did not detect open code. Researchers are encouraged to share open data when possible (see Nature blog).
Results from LimitationRecognizer: An explicit section about the limitations of the techniques employed in this study was not found. We encourage authors to address study limitations.Results from TrialIdentifier: No clinical trial numbers were referenced.
Results from Barzooka: We did not find any issues relating to the usage of bar graphs.
Results from JetFighter: We did not find any issues relating to colormaps.
Results from rtransparent:- Thank you for including a conflict of interest statement. Authors are encouraged to include this statement when submitting to a journal.
- Thank you for including a funding statement. Authors are encouraged to include this statement when submitting to a journal.
- No protocol registration statement was detected.
-